Genentech Announces Promising Phase III Results for Vamikibart in Treating Uveitic Macular Edema
- November 2, 2025
Rethinking Hormone Replacement Therapy After Breast Cancer: Experts Advocate for Patient-Centered Choices
When to Consider Exploring Clinical Trials with a Rare Diagnosis
Epioxa: FDA Approves First Incision-Free Cross-Linking Therapy for Keratoconus
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
🚨Urothelial bladder cancer often hides behind everyday symptoms like blood in the urine or frequent trips to the bathroom. But with the right tests, it doesn't stand a chance. 💥
🧪 Diagnosis starts with urine tests and moves to a cystoscopy that checks out your bladder lining. If anything looks off, doctors take a biopsy to confirm. Imaging like CT scans and MRIs help map out the cancer’s spread. And in some cases, genetic testing helps tailor treatment just for you.
🎯 Early detection = better outcomes. So if something feels off, speak up and get checked. Your health is worth it.
#BladderCancerAwareness #UrothelialCancer #KnowTheSigns #GetChecked #PatientWorthy
Genentech has shared hopeful results from phase 3 of a recent clinical trial for vamikibart, a new treatment designed to treat uveitic macular edema (a condition that stems from complications with uveitis or other uveal diseases). Read more here:
bit.ly/3X2rrw2
When a condition is syndromic, it means it doesn't exist alone but it's part of a bigger picture. Symptoms can overlap, systems can connect, and sometimes what looks like separate health issues actually share one underlying cause. For many living with a rare or chronic illness, this complexity is part of the diagnostic process. It's not "just one thing," and understanding the syndromic nature of a condition can be key to finding answers, treatments, and support. #RareDisease #ChronicIllness #RareWordOfTheWeek #PatientWorthy
